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Unilateral Epileptic Negative Myoclonus Following 
Focal Lesion of the Postcentral Cerebral Cortex Due 
to Acute Middle Cerebral Infarction
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Here we report a patient who suffered an acute infarction of the contralateral postcentral cerebral cortex and 
subsequently developed unilateral partial epilepsy with negative myoclonus. The findings of brain magnetic 
resonance imaging, polygraphic recordings of the postcentral somatosensory area, and response to anticonvulsant 
treatment support the presence of a cause-and-effect relationship, thereby providing evidence for a pathophysio-
logical substrate for epileptic negative myoclonus.
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INTRODUCTION
Negative myoclonus (NM) is a condition characterized 
by brief postural lapses of muscle tone, which can be 
demonstrated via electromyography (EMG) recordings.
1,2 
NM frequently occurs in association with metabolic 
encephalopathies. The EMG correlate of NM is a brief 
(<500 ms) silent period that is not preceded by any 
enhancement of EMG activity (i.e., myoclonus).
3 
Epileptic negative myoclonus (ENM) is defined as an 
interruption of tonic muscular activity that is time-locked 
to a spike on the electroencephalogram (EEG) without 
evidence of an antecedent myoclonus. ENM occurs in 
different epilepsy syndromes with a variety of etiologies; 
however, the exact origin of and mechanisms underlying 
the generation of ENM remain to be elucidated.
1 
Regarding the cortical areas that mediate NM, there is 
some evidence for the involvement of the perirolandic 
cortex, whereas studies on ENM have shown that this 
phenomenon may be associated with epileptic activity in 
the premotor cortex, including the supplementary motor 
area, or in the postcentral somatosensory cortex.
3,4
There have been a few reports on ENM since its first 
description in 1981,
4 but its association with strokes has 
not been described previously. Here we describe a 
patient who suffered an acute focal lesion as a result of 
a contralateral cerebral infarction; the stroke involved 
the right parietotemporal cortex, and the patient 
subsequently experienced the onset of unilateral partial 
motor epilepsy with NM, which is also referred to as an 
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Figure 1. Brain MRI showing acute ischemic changes in the 
inferior branch territory of the right middle cerebral artery, 
involving the parietotemporal region (postcentral cerebral cortex).
CASE REPORT
A 62-year-old right-handed man was admitted to 
hospital with sudden-onset speech disturbance and left 
hemiparesis that first appeared 12 hours previously. His 
past medical record revealed an infarct in the territory of 
the left carotid artery that had occurred 2 years 
previously. He also had a 5-year history of hypertension, 
which was well controlled. His daily medications 
included aspirin at 100 mg, atenolol at 25 mg, and 
phenytoin at 300 mg.
The patient was alert and oriented, with fluent but 
mildly dysarthric speech, left central-type facial palsy, 
mild left hemiparesis (MRC, GIV+/V), numbness of the 
left extremities, and mild ataxia of the left upper limb; 
he also exhibited dyssynergia, hypermetria, and tremor 
during the finger-to-nose test with the left hand. 
Laboratory parameters, including a complete blood cell 
and platelet count, erythrocyte sedimentation rate, blood 
electrolytes, creatinine, liver enzymes, cholesterol, trigly-
cerides, and prothrombin and partial thromboplastin 
time, were all normal. In addition, the serum level of 
phenytoin was 5.09 μg/ml.
Brain magnetic resonance imaging (MRI) performed 
on his admission revealed high signal intensities in the 
right parietotemporal cortex in both diffusion- and 
T2-weighted imaging (Fig. 1). One day later, when 
the patient had regained almost complete strength in his 
left hand, he complained of an abnormal movement of 
his face and arm. These movements consisted of inter-
mittent, involuntary, jerk-like movements of the left 
perioral area and arrhythmic losses of extensor muscle 
tone that developed upon instruction to maintain the 
wrist in an extended position. A waking, surface EEG 
revealed periodic epileptic discharges on the right 
parietotemporal area (mainly on leads T6 and P4). 
Polygraphic recordings, including the EEG and the 
surface EMG of the extensor wrist muscles, were 
performed to verify unilateral postural lapses of the left 
arm. With the patient’s left upper limb at rest, the EEG 
epileptic discharges were not accompanied by any motor 
signs. EEG epileptic discharges in the right parie-
totemporal area occurred when the left upper limbs were 
outstretched, which were accompanied by 200- to 500- 
ms silent periods on surface EMG recording of the left 
wrist extensor muscles, and these provoked postural 
lapses of muscle tone (Fig. 2). The somatosensory- 
evoked potential recording (SEP) that was obtained 
following stimulation of the left median nerve showed 
normal latency and configuration findings, except for the 
decreased amplitude. These polygraphic recordings and 
SEP findings suggested the presence of ENM. The 
patient was treated daily with aspirin at 300 mg, 
dipyridamole at 400 mg, valproic acid at 2000 mg, and 
phenytoin at 200 mg. These adjustment of the patient’s 
epileptic drugs resulted in an almost complete dis-
appearance of both the ENM and the abnormal EEG 
epileptic discharges (Fig. 3).
DISCUSSION
ENM must be differentiated from nonepileptic 
positive myoclonus and asterixis, where the latter is not 
associated with the time-locked EEG correlates. Positive 
myoclonus can be ascertained easily by polygraphic 
recordings of the agonist and antagonist muscles.
5 In our 
patient, simultaneous EEG and EMG polygraphic 
recordings showed postural lapses of muscle tone, which 
were time-locked with a sharp or spike wave over the 
contralateral parietotemporal cortex. Therefore, the most 
interesting feature in our patient was the peculiar focal Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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Figure 2. EMG silent periods lasting up to about 400 ms appear 
irregularly, interrupting the ongoing interferential recorded from 
the left extensor muscle. The silent periods are time-locked with 
the epileptic discharges recorded from the contralateral parieto-
temporal region.
Figure 3. Combined EMG and EEG polygraphic recordings 
made after the patient’s antiepileptic agents were adjusted. The 
continuous muscle contractions without silent periods are 
evident; the EEG also shows only mixed slowing waves without 
epileptic discharges on the right parietotemporal region.
inhibition of muscle tone related to EEG spikes that was 
not associated with myoclonic jerks.
The pathogenetic mechanism of ENM remains obscure, 
and that of the ENM evident in this patient also remains 
speculative. Ikeda et al. found that activation of the 
perirolandic cortex can produce pure NM, and they also 
provided evidence of the capability of the nonprimary 
motor areas – such as the premotor cortex and supple-
mentary motor cortex – to generate NM.
6 It was reported 
that using single electrical pulses to stimulate the 
premotor cortex, the primary motor cortex, the primary 
somatosensory cortex, and the supplementary motor area 
through stereo-EEG electrodes could induce pure silent 
periods on the EMG findings related to NM, not 
preceded by a motor evoked potential, which clinically 
appear as NM. These findings suggests that these cortical 
areas are involved in the genesis of NM.
3,7 However, 
previous authors have pointed out that stimulation of the 
supplementary motor area induces only pure silent 
periods, regardless of the stimulus intensity, whereas the 
occurrence of pure silent periods following stimulation 
of the premotor cortex, primary motor cortex, and 
primary somatosensory area depend mainly on the 
stimulation intensity.
3,7 This episodic dysfunction within 
the neural circuits that are normally concerned with the 
maintenance of sustained or tonic muscle contraction, 
so-called NM, may be released by focal lesions that are 
only in specific CNS areas or by a more generalized 
neurochemical imbalance (metabolic encephalopathies of 
various kinds, such as hepatic encephalopathy, renal and 
respiratory failure, and electrolyte imbalances).
8,9 Several 
authors have also reported that high-frequency trains of 
electrical stimuli delivered directly to the negative motor 
area, including the premotor cortex, the primary motor 
cortex, the primary somatosensory cortex, and the 
supplementary motor area, can produce sustained 
negative motor responses, such as behavioral arrest, 
motor slowing, and inability to maintain a tonic 
contraction.
3,10 Therefore, regarding the pathogenesis of 
ENM in our patient, we speculate that the lesion 
involving the parietotemporal cortex gives way to a 
strong intensity of abnormal electrical stimulation this 
intensity of electrical stimulation, which might be 
sufficient to effect pure silent periods, could spread from 
the postcentral cerebral cortex to the adjacent motor 
areaand thereby evoke pure silent periods, so-called 
ENM.
It is possible that the ENM in our patient was 
produced by either a metabolic imbalance or by 
neuropharmacologic agents, which caused a drug- 
induced encephalopathy.
11-13 However, the relationships 
between the MRI and polygraphic evidence involving 
the postcentral somatosensory area and the response to 
anticonvulsant treatment, as well as the absence of other 
responsible etiologies, favors the argument of a cause Song IU, et al. Unilateral Epileptic Negative Myoclonus Following Focal Lesion of the Postcentral Cerebral Cortex
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-and-effect relationship, and this evidence weighs against 
the observations being coincidental. Despite a common 
cortical origin and some similarities in clinical semi-
ology, to our knowledge, ENM and NM are two distinct 
entities. On the basis of several reports mentioned above 
and our own experience, ENM can be easily mis-
diagnosed. Thus, the appearance of ataxia, postural 
instability, or clumsiness in a patient with epileptic 
activity should suggest ENM when the symptoms cannot 
be ascribed to metabolic encephalopathy (including 
drug toxicity) or to progressive disease.
To the best of our knowledge, there are few reports 
on ENM-associated stroke in the medical literature, and 
there is still no consensus regarding the pathological 
mechanism underlying ENM. The case presented here 
suggests that a destructive lesion of the postcentral 
cerebral cortex and alteration of its outflow pathways to 
the neighboring motor area can lead to ENM.
REFERENCES
 1. Noachtar S., Holthausen H., Lüders HO. Epileptic ne-
gative myoclonus. Subdural EEG recordings indicate a 
postcentral generator. Neurology 1997;49:1534-1537.
 2. Shibasaki H. Pathophysiology of negative myoclonus and 
asterixis. In: Fahn S, Hallett M, Luders HO, Marsden CD 
(eds) Negative Motor Phenomena. Philadelphia; Lippincott- 
Raven, 1995;199-210.
 3. Rubboli G, Mai R, Meletti S, Francione S, Cardinale F, 
Tassi L, et al. Negative myoclonus induced by cortical 
electrical stimulation in epileptic patients. Brain 2006;129: 
65-81.
 4. Guerrini R, Dravet C, Genton P, Bureau M, Roger J, 
Rubboli G, et al. Epileptic negative myoclonus. Neurology 
1993;43(6):1078-1083.
  5. Cirignotta F, Lugaresi E. Partial motor epilepsy with 
“negative myoclonus”. Epilepsia 1991;32:54-58.
 6. Ikeda A, Ohara S, Matsumoto R, Kunieda T, Nagamine T, 
Miyamoto S, et al.Role of primary sensorimotor cortices 
in generating inhibitory motor response in humans. Brain 
2000;123:1710-1721.
  7. Nighoghossian N, Trouillas P, Vial C, Froment JC. 
Unilateral upper limb asterixis related to primary motor 
cortex infarction. Stroke 1995;26:326-328.
 8. Stell R, Davis S, Carroll WM. Unilateral asterixis due to 
a lesion of the ventrolateral thalamus. J Neurol Neurosurg 
Psychiatry 1994;57:878-880.
 9. Young RR, Shahani BT. Asterixis: one type of negative 
myoclonus.  Adv Neurol 1986;43:137-156.
10. Lim SH, Dinner DS, Pillay PK, Lüders H, Morris HH, 
Klem G, et al. Functional anatomy of the human supple-
mentary sensorimotor area: results of extraoperative 
electrical stimulation. Electroencephalogr Clin Neurophysiol 
1994;91:179-193.
11. Young RR, Shahani BT, Anticonvulsant asterixis. 
Electroencephalogr Clin Neurophysiol 1973;34:760a.
12. Rittmannsberger H. Asterixis induced by psychotropic 
drug treatment. Clin Neuropharmacol 1996;19:349-355.
13. Duarte J, Sempere AP, Cabezas MC, Marcos J, Claveria 
LE. Postural myoclonus induced by phenytoin. Clin Neuro-
pharmacol 1996;19:536-538.